首页> 外文期刊>American Journal of Transplantation >Cyclophilin A and Nuclear Factor of Activated T Cells Are Essential in Cyclosporine-Mediated Suppression of Polyomavirus BK Replication
【24h】

Cyclophilin A and Nuclear Factor of Activated T Cells Are Essential in Cyclosporine-Mediated Suppression of Polyomavirus BK Replication

机译:亲环蛋白A和活化的T细胞的核因子在环孢菌素介导的多瘤病毒BK复制的抑制中是必不可少的。

获取原文
获取原文并翻译 | 示例
           

摘要

Immunosuppressants have impacts on the development of polyomavirus-associated nephropathy. We previously demonstrated that cyclosporin A (CsA) suppressed polyomavirus BK (BKV) replication. The role of cyclophilin A (CypA) and nuclear factor of activated T cells (NFAT) in CsA-imposed suppression of BKV replication was determined in this study. Results demonstrated that knockdown of CypA but not CypB significantly reduced BKV large T antigen (TAg) expression and BKV titer. Overexpression of CypA reversed CypA siRNA-induced inhibition in BKV TAg expression. In addition, CypA overexpression attenuated the suppressive effect of CsA on TAg expression, suggesting CypA implicated in CsA-mediated anti-BKV effect. Knockdown of NFATc3 abrogated TAg expression, while overexpression of NFATc3 promoted TAg expression and augmented BKV promoter activity. NFATc3 binding to the BKV promoter was verified by chromatin immunoprecipitation assay and electrophoretic mobility shift assay. Renal histology also displayed an increase in NFATc3 expression in tubulointerstitium of BKV-associated nephropathy. Furthermore, overexpression of NFATc3 rescued CsA-mediated inhibition of BKV load and TAg expression. A CsA analog, NIM811, which cannot block NFAT functionality, failed to suppress TAg expression. In conclusion, CypA and NFAT are indispensable in BKV replication. CsA inhibits BKV replication through CypA and NFAT, which may be potential targets of anti-BKV treatment.
机译:免疫抑制剂对多瘤病毒相关性肾病的发展有影响。我们以前证明环孢菌素A(CsA)抑制了多瘤病毒BK(BKV)复制。在这项研究中确定了亲环蛋白A(CypA)和活化T细胞核因子(NFAT)在CsA施加的BKV复制抑制中的作用。结果表明敲除CypA而不降低CypB可以显着降低BKV大T抗原(TAg)表达和BKV滴度。 CypA的过表达逆转了CypA siRNA诱导的BKV TAg表达抑制。此外,CypA的过表达减弱了CsA对TAg表达的抑制作用,表明CypA与CsA介导的抗BKV效应有关。击倒NFATc3废除了TAg的表达,而NFATc3的过表达促进TAg的表达并增加BKV启动子的活性。通过染色质免疫沉淀测定法和电泳迁移率变动测定法验证了NFATc3与BKV启动子的结合。肾脏组织学还显示,BKV相关性肾病的肾小管间质中NFATc3表达增加。此外,NFATc3的过表达挽救了CsA介导的BKV负荷和TAg表达的抑制。无法阻止NFAT功能的CsA类似物NIM811无法抑制TAg表达。总之,CypA和NFAT在BKV复制中是必不可少的。 CsA通过CypA和NFAT抑制BKV复制,这可能是抗BKV治疗的潜在目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号